JIM3 Cell Line

JIM3 was established from plasma myeloma cells derived from pleural fluid of an advanced multiple myeloma patient, and is homoplastic with the cell line JIM1. It allows in vitro study and comparison of genetic instability in myeloma tumour lines and in vitro study of the effects of DNA repair deficiency in myeloma tumour lines.

Contributors

Inventor Institute
M.S. Hamilton University of Birmingham
Cat. #: 151450
Tool sub type: Primary
Unit size: 1×10^6 cells / vial
Cancer types: Blood cancer;Blood cancer
Organism: Human
Tissue: Blood
Gender: Female
Model: Tumour line
Cancer Types In Detail: Human multiple myeloma;Human multiple myeloma
Product description: JIM3 is a multiple myeloma cell line established from plasma myeloma cells derived from pleural fluid of an advanced multiple myeloma patient (Hamilton et al., 1991). JIM3 carries compound mutations in KRAS (G12D heterozygous) and TP53 (R273C homozygous) (Moreaux et al., 2011). The cell line exhibits deficient DNA mismatch repair capacity with reduced G/T repair activity, and microsatellite instability (Velangi et al 2004). JIM3 displays a plasma cell phenotype and is a model for studying compound genetic lesions, DNA repair deficiency and genomic instability in multiple myeloma research.
Gender: Female
CRISPR: Yes
Conditional: Yes
Production details: Derived from plasma myeloma cells from pleural fluid of advanced multiple myeloma female patient.
Cellosaurus ID: CVCL_2533
disease: Cancer;Cancer
Format: Frozen
Shipping conditions: Dry ice
Growth medium: Dexter culture medium, consisting of Fischer's medium + 20% FCS +10-7 M hydrocortisone sodium succinate. Seed at 2-9 x 10 5 cells/cm3 5% CO2; 37 °C
Mycoplasma free: Yes
References:

Hamilton M.S. et al. 1991. Leukemia. 5:768-771. PMID: 1943229

Bergsagel P.L. et al. 1996. Proc. Natl. Acad. Sci. U.S.A. 93:13931-13936. PMID: 8943038

Sakai A. et al. 1998. Blood. 92:3410-3415. PMID: 9787181

Kuipers J. et al. 1999. Cancer Genet. Cytogenet. 109:99-107. PMID: 10087940

Drexler H.G. et al. 2000. Leuk. Res. 24:681-703. PMID: 10936422

Chesi M. et al. 2001. Blood. 97:729-736. PMID: 11157491

Velangi et al. 2004. Carcinogenesis. 25(10):1795-803. PMID: 15142887

Bataille F.-R. et al. 2006. Haematologica. 91:1234-1240. PMID: 16956823

Keats J.J. et al. 2007. Cancer Cell. 12:131-144. PMID: 17692805

Dib A. et al. 2008. J. Natl. Cancer Inst. Monogr. 39:25-31. PMID: 18647998

Leone et al. 2008. Clin Cancer Res. 14(19):6033-41. PMID: 18829482

Moreaux J. et al. 2011. Haematologica. 96:574-582. PMID: 21173094

Maiga S. et al. 2015. Cytometry A. 87:285-288. PMID: 25688540

Tessoulin B. et al. 2018. J. Hematol. Oncol. 11:137.1-137.13. PMID: 30545397

Sarin V. et al. 2020. Leukemia. 34:2754-2765. PMID: 32123307.

Citations And Reviews

Related Tools for Cell lines

Cat. # Tool Name
151014 MCF7 AREc32 Cell Line Key Info View Tool
151558 MEF Trex1 KO Cell Line Key Info View Tool
151665 MEF PKCe KO Cell Line Key Info View Tool
151673 PEO4 Cell Line Key Info View Tool
151448 CMT 167 Cell Line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.